Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • FSLR vs GSK✓SelectedUSD · GSKFSLR vs GSK performance historyLatest closeAs of-9.45%11/20
Stock and ETF performance explorer

FSLR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+368.3%
GSK return
+97.4%
Excess return
+270.9%
Maximum drawdown
-61.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-9.5%-0.1%-9.3%-9.4%
7D-19.7%-5.3%-14.4%-18.8%
30D-21.3%-3.7%-17.6%-20.7%
3M-35.7%-7.3%-28.5%-34.8%
6M-42.2%-4.2%-37.9%-41.9%
YTD-47.3%+0.9%-48.2%-47.9%
1Y-44.0%+7.3%-51.3%-45.5%
3Y-13.6%+52.7%-66.4%-24.9%
5Y+27.0%+40.1%-13.2%+10.8%
All+368.3%+97.4%+270.9%+240.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling